The Medical Journal of Australia ISSN: 0025-729X 1 October 2012 197 7 378-378 ©The Medical Journal of Australia 2012 www.mja.com.au Perspective n an earlier article we discussed the need for better science in improving health care effectiveness. 1 In this article, we focus on the need for better translation of valid and relevant science into routine clinical practice. The path from research to improved patient outcomes has been likened to a "leaky pipe", which comprises seven sequential steps of evidence translation: (i) awarenessthe clinician is aware of valid and relevant research; (ii) acceptance -the clinician accepts that the research should alter current practice; (iii) applicability -the clinician uses interventions in patients who stand to benefit most and avoids interventions in patients who might be harmed; (iv) ability -the clinician feels confident that delivering an intervention is within his or her capacity; (v) acted on -the clinician remembers to consider and prescribe the intervention appropriately; (vi) agreement -the patient accepts the prescribed treatment plan; and (vii) adherence -the patient consistently adheres to the treatment plan. 2 Leakage from (or "falls in pressure") throughout this clinicianawareness-to-patient-adherence pipeline helps explain why, on average, no more than a third of evidence-based clinical guideline recommendations are routinely adhered to (based on clinician and patient self-report), 3 and no more than 60% of patients at any one time receive the care deemed appropriate by current science (based on case reviews). 4 This article presents evidence-based effective means for overcoming evidence-translation barriers. 5, 6 1. Insufficient awareness or acceptance of high-quality evidence Clinicians (defined here as any certified health professional) must be prepared to question the level of evidentiary certainty underpinning clinical decisions, and actively seek and adopt new evidence that may better inform such decisions, even if this means reversing widely held beliefs and practices. Between 20% and 30% of clinical interventions may be unnecessary or even harmful on the basis of current evidence. 4, 7, 8 Some examples are listed in Box 1.
Clinicians need to have the skills to quickly locate and interpret the 7% of published research scattered among hundreds of journals that is valid, has clinically meaningful impact, and is applicable to many patients. 9 The vast amount of "marketing-based evidence" that is false or misleading can then be quickly dismissed. Accessing and using systematic reviews and secondary sources of prefiltered, preappraised research accelerates evidence uptake. 10 Clinicians skilled in evidence-based medicine (EBM) appear to provide better-quality care.
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Recommendations
Develop and assess EBM skills among clinicians:
The acquisition of EBM skills should be part of the core curricula of all medical schools and specialist colleges and students should be assessed on these skills. Curricula need to integrate learning of EBM into bedside medicine, clinical tutorials and journal clubs in ways that foster appropriate skills and attitudes.
14 Performance appraisals and continuing professional development programs should award credits for activities that maintain and enhance EBM skills.
Provide user-friendly EBM infrastructure: Wherever clinicians work, access should be guaranteed to well designed evidence databases and decision-support systems. 15 Reliable search engines such as PubMed Clinical Queries, Cochrane Library and Evidence Updates (BMJ) should be available at every computer workstation.
Generate reliable evidence-based guidance: Professional organisations working with government bodies such as the Australian Commission on Safety and Quality in Health Care (ACSQHC) need to define minimum evidence-based (not opinion-based) practice standards for common conditions associated with a high disease burden.
Clinical guideline recommendations should be unambiguous and consistent, and define target patient populations and expected clinical outcomes. Clinically trained, non-conflicted content experts and methodologists should collaborate in guideline development panels that use structured and transparent processes for grading the quality of evidence and the strength of recommendations. 16 The occurrence of conflicting recommendations in different guidelines must be minimised by consensus processes operating across professional jurisdictions. 17 Clinicians charged with • Many barriers thwart the uptake of valid and clinically important research into practice, with cognitive, motivational and sociological factors on the part of health professionals being among the most important.
• Encouraging clinicians to question the level of scientific certainty underpinning clinical practice and to actively seek evidence that may better inform clinical decisions is a priority for improving health care effectiveness.
• Although there are effective strategies for improving translation of research into practice, implementing them requires agreement between and buy-in from professional and managerial stakeholders.
Summary
implementing local guidelines should collaborate with others within their practice settings in developing agreed best practices that account for local contexts. 18 Such localised guidelines then need to be made readily accessible at the point of care, and implemented in ways that highlight key decision points and target less experienced or more isolated clinicians most in need of guidance. 19 Guidelines need to be updated regularly and should emphasise discontinuation of established practices that new evidence shows to be inappropriate (Box 1), and avoidance of interventions for which evidence of effectiveness is lacking (such as some off-label prescribing). When new drugs or devices become listed for public subsidy, before adopting them, clinicians should seek out rigorous assessments of efficacy from independent sources such as the National Prescribing Service Rational Assessment of Drugs and Research (RADAR) and Diagnostics Initiative (available at http:// www.nps.org.au/health_professionals/), and national registry studies (for prostheses, devices and procedures).
Restrict commercial influences in clinician education and practice: Misleading claims in journal advertisements, educational events, and media releases paid for by industry distract clinicians from valid, high-quality evidence and should attract hefty sanctions and penalties. Some medical journals such as PLoS Medicine have dispensed with all commercial advertising, relying instead on income from subscribers and non-commercial sources (eg, government health departments and research agencies). Disclosure of all industry funding of expert opinionmakers, conference organisers and practising clinicians should be mandated.
Suboptimal targeting of clinical interventions
Clinicians often undertreat patients at high absolute risk of disease events and overtreat lower-risk patients or those with irreversibly poor prognosis. 20 This risk-treatment paradox is pervasive, particularly in older populations, where underuse and overuse of interventions is a significant contributor to avoidable mortality and hospitalisation. 21 
Recommendations
Promote the use of risk prediction tools: Professional bodies, guideline writing groups and the ACSQHC should promote greater use of validated, easy-to-use risk prediction tools that enable clinicians and patients to better estimate individual absolute risk of treatment benefit and harm. A recently updated guideline on antithrombotic treatment in acute coronary syndromes includes risk calculators for determining the trade-off between a decreased risk of cardiovascular events and an increased risk of bleeding. 22 Promote wider use of care standards and indicators in routine practice: Senior personnel within hospital departments, Medicare Locals, large private group practices and public health facilities should embed Strict heart rate control
Chronic atrial fibrillation
Guidelines recommended strict rate control, but a randomised trial showed lenient control was equally effective and easier to achieve. 23 In maximising compliance with such indications, condition-specific clinical indicators need to be measured continuously or regularly, and results fed back to relevant clinicians. 24 Standardised electronic medical records and discharge summaries, clinical registries and administrative datasets can supply the necessary data for feedback in a timely manner. Such feedback has more impact if combined with comparative peer analyses and "how to improve" information and used to develop multidisciplinary quality improvement plans. 24 
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Impaired ability or inadequate incentives to enact evidence-informed decisions
High-quality evidence, even if known and accepted by clinicians, may not guarantee appropriate clinical actions because of limited applicability of evidence to specific patient circumstances; limited clinician self-efficacy (ability to provide required care); professional norms, organisational structures and culture that oppose changes to traditional practice; and the extra effort, time and resources that more appropriate decisions may entail for both clinicians and patients. 25, 26 Clinicians may also perceive evidence as inferior to organisational clout in influencing policymakers involved in resource allocation decisions.
Recommendations
Provide incentives for clinicians to consistently adopt evidenceinformed practice: Implementation science has yielded many evidence-based behaviour change strategies, [27] [28] [29] [30] which share three key elements: (i) raising awareness of evidence-practice gaps (creating impetus for change); (ii) devising, implementing, testing and refining change strategies (creating the "how-to"); and (iii) dealing with enablers and barriers (creating sustainability and widespread diffusion of change). Box 2 summarises change strategies relevant to clinical microsystems (general practice, specialist clinic, and hospital-unit or ward-based teams) or communities of practice (professional craft groups, networks and collaborations). Research suggests that such strategies can improve the proportion of patients who receive guideline-concordant care by between 6% and 16%. 29 Engagement and leadership of clinicians is crucial; strategies unilaterally mediated by managers, such as publicly reported scorecards, service accreditation and pay-for-performance schemes, have shown little evidence of effect on quality of care. 29 Align incentives/disincentives to support evidence-informed practice: Health care organisations can suffer loss of 2 Behaviour change strategies for promoting wider use of evidence by individual clinicians in group practices and hospitals Raising awareness of new practice-changing evidence and generating motivation to change
• Present new evidence at journal clubs, grand rounds, conferences (ideally interdisciplinary); raise common problems in the format of clinical questions; request expert facilitators to provide evidence supporting their recommendations (evidence-pull strategy).
• Raise awareness of new sentinel evidence (that discredits existing clinical practices or strongly mandates new practice) using journal-scanning services (evidence-push strategy).
• Raise awareness of disagreement between peers about what constitutes appropriate care for a commonly encountered clinical problem; convene focus groups that aim to achieve an evidence-based consensus.
• Publicise and use role models and senior opinion leaders who actively retrieve and apply evidence in changing routine care.
• Arrange interactive workshops or online courses that aim to improve evidence-based practice skills.
• Use academic detailing, train-the-trainer strategies, quality circles and learning collaboratives to educate wider audiences about desirable changes in practice.
• Develop and format guidelines, pathways and toolkits that make it easier for clinicians to learn new changes in practice.
Devising and implementing change on the basis of evidence
• Convene interdisciplinary meetings to formulate evidence-based best-practice standards, identify evidence-practice gaps from audits and consider practice changes to close the gaps.
• Conduct focus group discussions and undertake process mapping to identify evidence-practice gaps and predisposing contextual factors.
• Assess readiness for change within clinician groups and identify implementation barriers.
• Review available evidence about others' experience in instituting practice changes and undertake site visits to locations where similar implementation efforts have been successful.
• Recruit, designate and train clinical leaders for the change effort; build partnerships with agencies (eg, academic units, quality and safety improvement units) for shared training and research collaborations.
• Test feasibility of changes to practice at the local level with simulation or modelling exercises, small pilots or demonstration projects before full-scale roll-out.
Sustaining and embedding change into routine care
• Cultivate and support experts, clinical champions and respected peers who encourage change.
• Involve existing governance structures (eg, clinical councils, medical staff associations, practice boards) in providing oversight and support for full-scale implementation.
• Seek advocacy for change from informed patients, carers and patient advocates, and involve them in implementation efforts.
• Disseminate results of change to others (eg, through small group discussion, clinical presentations, newsletters, mass media) to motivate others to introduce change.
• Use evidence-based clinical pathways, checklists, reminders, prompts, teaching resources and other decision support to reinforce change.
• Develop and implement quality monitoring systems that allow an ongoing audit of practice and effects of change implementation, and ensure results are widely distributed.
• Revise professional roles and reconfigure clinical teams in ways that make it more likely for clinical innovation to be achieved. 31,32 Box 3 details organisational-level strategies used to support evidence-based practice, 33, 34 which should be scrutinised by service accreditation programs.
Avoid financial reimbursement for interventions of nil or uncertain benefit: Interventions that robust evidence shows to be ineffective, or for which evidence of benefit is lacking, should not be subsidised by public or private health insurance programs. Despite the best efforts of the Pharmaceutical Benefits Advisory Committee and Medicare Services Advisory Committee, new uses and indications of existing drugs, tests and procedures commonly bypass such scrutiny. 35 
Inability to gain patient adherence
Health care effectiveness is considerably compromised by levels of patient adherence to appropriate care, which currently average no more than 50%. 36 
Recommendations
Endorse strategies to improve patient adherence to agreed medical advice: Virtually all interventions for enhancing medication adherence that are at least partially effective involve combinations of more simplified and convenient dosing, reminders, self-management and reinforcement, and personalised outreach (phone calls or home visits). 36 Enhance clinician skills in individualising patient care: Eliciting patients' needs and preferences, providing personalised estimates of treatment risk and benefit, and identifying and ameliorating patient-perceived barriers to compliance improves patient acceptance and adherence to 4 Key questions that characterise shared decision making*
• What do you expect from investigation and/or treatment of your condition?
• Do you have all the information you think you need to weigh up the various options?
• Thinking about this decision, what is the most important aspect for you to consider?
• What aspects of management (eg, tests, drugs, procedures or surgery) are you most concerned about?
• How do the benefits of the various options compare?
And how do the harms compare?
• Are there important other people that you want to talk to in making this decision? *Adapted from Stiggelbout et al. 38 ◆ 3 Organisational strategies for supporting evidence-based practice Active commitment and support from senior managers (in hospitals, general practice, specialist group practices and public health organisations)
• Openly endorse evidence-based learning and continuous quality improvement within mission statements and operations of boards, directorships and other subagencies of the organisation.
• Provide dedicated time, physical resources and remuneration for clinicians to practice evidence-based care; schedule 10% of normal working hours to be spent on evidence-based practice-related activities (eg, journal clubs, clinical audits, quality and safety reviews).
• Recognise those who have championed evidence-based practice within the organisation through recognition awards, sponsorship of presentations at professional meetings or credits for participation in professional development courses.
Use of evidence to inform care delivery
• Establish interdisciplinary panels for developing and updating evidence-based clinical standards, guidelines or pathways applicable to key areas of practice within the organisation.
• Establish organisation-wide literature search services that staff can use to retrieve relevant high-quality evidence in answering important clinical questions.
• Sponsor clinician-led, organisation-wide restructuring of care processes and service delivery systems in accordance with evidence of effectiveness in optimising care.
• Mandate that submissions for new clinical technologies or services include a rationale based on a systematic review of evidence of effectiveness compared with existing care.
• Develop payment formulae that fully remunerate high-value evidence-based practice while disinvesting in interventions that robust evidence shows to be of no or very marginal benefit.
• Deploy performance appraisal and credentialling policies that restrict the scope of practice of clinicians whose practice is consistently in violation of accepted evidence-based standards.
• Waive professional indemnity from litigation in cases where care resulting in serious patient harm was in clear violation of accepted evidence-based standards.
Alignment of evidence-based practice with quality and safety improvement
• Foster wide recognition that evidence-based practice and quality and safety improvement complement and reinforce one another.
• Establish clinician-led quality and safety teams at the level of group practices and hospital units or departments to identify and remediate shortfalls in care according to the best available evidence.
• Provide the necessary infrastructure for measuring and providing feedback on defined sets of key clinical indicators for commonly encountered conditions and procedures.
• Support the creation of clinical registries that monitor care processes and outcomes relating to key areas of practice within the organisation.
• Maintain an up-to-date inventory of evidence-based quality and safety improvement interventions relevant to key areas of practice within the organisation.
• Participate in evidence-based quality and safety improvement collaborations with other like-minded organisations.
• Emphasise the integration of an evidence-based quality and safety improvement framework with mainstream care when seeking organisational accreditation. ◆ management plans. 37, 38 Shared decision making (Box 4) helps patients to be more selective about treatments and invasive procedures, and helps reduce potentially inappropriate polypharmacy in older patients with multiple comorbidities. 39 Where patients request ineffective interventions, clinicians should stand by the evidence and offer alternative care of proven value. 40 
Conclusion
A sustainable, best-value health care system requires awareness of, and system-wide commitment to, the barriers and enablers of evidence-informed care affecting individual clinicians and health care services. Generating and testing strategies for bridging evidence-practice gaps will be an ongoing need in rendering clinical medicine more effective.
